Search results:

Gene ID	Symbol	Synonyms	Official Full Name	Location
The pahtway p161 has 72 genes in the original annotation. Currently, there are 56 genes in SZGR (with evidence in schizophrenia) that are present at this pathway.
3688	ITGB1	CD29 \| FNRB \| GPIIA \| MDF2 \| MSK12 \| VLA-BETA \| VLAB	integrin subunit beta 1	10p11.2
7189	TRAF6	MGC:3310 \| RNF85	TNF receptor associated factor 6	11p12
5970	RELA	NFKB3 \| p65	v-rel avian reticuloendotheliosis viral oncogene homolog A	11q13
3458	IFNG	IFG \| IFI	interferon, gamma	12q14
4792	NFKBIA	IKBA \| MAD-3 \| NFKBI	NFKB inhibitor alpha	14q13
7043	TGFB3	ARVD \| ARVD1 \| LDS5 \| RNHF \| TGF-beta3	transforming growth factor beta 3	14q24
2353	FOS	AP-1 \| C-FOS \| p55	FBJ murine osteosarcoma viral oncogene homolog	14q24.3
5579	PRKCB	PKC-beta \| PKCB \| PRKCB1 \| PRKCB2	protein kinase C beta	16p11.2
5595	MAPK3	ERK-1 \| ERK1 \| ERT2 \| HS44KDAP \| HUMKER1A \| P44ERK1 \| P44MAPK \| PRKM3 \| p44-ERK1 \| p44-MAPK	mitogen-activated protein kinase 3	16p11.2
4843	NOS2	HEP-NOS \| INOS \| NOS \| NOS2A	nitric oxide synthase 2	17q11.2
718	C3	AHUS5 \| ARMD9 \| ASP \| C3a \| C3b \| CPAMD1 \| HEL-S-62p	complement component 3	19p13.3-p13.2
4793	NFKBIB	IKBB \| TRIP9	NFKB inhibitor beta	19q13.1
7040	TGFB1	CED \| DPD1 \| LAP \| TGFB \| TGFbeta	transforming growth factor beta 1	19q13.1
3716	JAK1	JAK1A \| JAK1B \| JTK3	Janus kinase 1	1p32.3-p31.3
2215	FCGR3B	CD16 \| CD16b \| FCG3 \| FCGR3 \| FCR-10 \| FCRIII \| FCRIIIb	Fc fragment of IgG receptor IIIb	1q23
2212	FCGR2A	CD32 \| CD32A \| CDw32 \| FCG2 \| FCGR2 \| FCGR2A1 \| FcGR \| IGFR2	Fc fragment of IgG receptor IIa	1q23
5743	PTGS2	COX-2 \| COX2 \| GRIPGHS \| PGG/HS \| PGHS-2 \| PHS-2 \| hCox-2	prostaglandin-endoperoxide synthase 2	1q25.2-q25.3
3586	IL10	CSIF \| GVHDS \| IL-10 \| IL10A \| TGIF	interleukin 10	1q31-q32
1378	CR1	C3BR \| C4BR \| CD35 \| KN	complement component 3b/4b receptor 1 (Knops blood group)	1q32
3460	IFNGR2	AF-1 \| IFGR2 \| IFNGT1 \| IMD28	interferon gamma receptor 2 (interferon gamma transducer 1)	21q22.11
3689	ITGB2	CD18 \| LAD \| LCAMB \| LFA-1 \| MAC-1 \| MF17 \| MFI7	integrin subunit beta 2	21q22.3
5594	MAPK1	ERK \| ERK-2 \| ERK2 \| ERT1 \| MAPK2 \| P42MAPK \| PRKM1 \| PRKM2 \| p38 \| p40 \| p41 \| p41mapk \| p42-MAPK	mitogen-activated protein kinase 1	22q11.21
10454	TAB1	3'-Tab1 \| MAP3K7IP1	TGF-beta activated kinase 1/MAP3K7 binding protein 1	22q13.1
4689	NCF4	NCF \| P40PHOX \| SH3PXD4	neutrophil cytosolic factor 4	22q13.1
5600	MAPK11	P38B \| P38BETA2 \| PRKM11 \| SAPK2 \| SAPK2B \| p38-2 \| p38Beta	mitogen-activated protein kinase 11	22q13.33
6300	MAPK12	ERK-6 \| ERK3 \| ERK6 \| MAPK 12 \| P38GAMMA \| PRKM12 \| SAPK-3 \| SAPK3	mitogen-activated protein kinase 12	22q13.33
3552	IL1A	IL-1A \| IL1 \| IL1-ALPHA \| IL1F1	interleukin 1 alpha	2q14
3553	IL1B	IL-1 \| IL1-BETA \| IL1F2	interleukin 1 beta	2q14
6772	STAT1	CANDF7 \| IMD31A \| IMD31B \| IMD31C \| ISGF-3 \| STAT91	signal transducer and activator of transcription 1	2q32.2
4615	MYD88	MYD88D	myeloid differentiation primary response 88	3p22
3592	IL12A	CLMF \| IL-12A \| NFSK \| NKSF1 \| P35	interleukin 12A	3q25.33
4790	NFKB1	CVID12 \| EBP-1 \| KBF1 \| NF-kB1 \| NF-kappa-B \| NF-kappaB \| NFKB-p105 \| NFKB-p50 \| NFkappaB \| p105 \| p50	nuclear factor of kappa light polypeptide gene enhancer in B-cells 1	4q24
7097	TLR2	CD282 \| TIL4	toll like receptor 2	4q32
3565	IL4	BCGF-1 \| BCGF1 \| BSF-1 \| BSF1 \| IL-4	interleukin 4	5q31.1
3593	IL12B	CLMF \| CLMF2 \| IL-12B \| IMD28 \| IMD29 \| NKSF \| NKSF2	interleukin 12B	5q33.3
3108	HLA-DMA	D6S222E \| DMA \| HLADM \| RING6	major histocompatibility complex, class II, DM alpha	6p21.3
3109	HLA-DMB	D6S221E \| RING7	major histocompatibility complex, class II, DM beta	6p21.3
3111	HLA-DOA	HLA-DNA \| HLA-DZA \| HLADZ	major histocompatibility complex, class II, DO alpha	6p21.3
3112	HLA-DOB	DOB	major histocompatibility complex, class II, DO beta	6p21.3
3113	HLA-DPA1	DP(W3) \| DP(W4) \| HLA-DP1A \| HLADP \| HLASB \| PLT1	major histocompatibility complex, class II, DP alpha 1	6p21.3
3115	HLA-DPB1	DPB1 \| HLA-DP \| HLA-DP1B \| HLA-DPB	major histocompatibility complex, class II, DP beta 1	6p21.3
3117	HLA-DQA1	CD \| CELIAC1 \| DQ-A1 \| GSE \| HLA-DQA	major histocompatibility complex, class II, DQ alpha 1	6p21.3
3118	HLA-DQA2	DX-ALPHA \| HLA-DXA	major histocompatibility complex, class II, DQ alpha 2	6p21.3
3119	HLA-DQB1	CELIAC1 \| HLA-DQB \| IDDM1	major histocompatibility complex, class II, DQ beta 1	6p21.3
3122	HLA-DRA	HLA-DRA1 \| MLRW	major histocompatibility complex, class II, DR alpha	6p21.3
3123	HLA-DRB1	DRB1 \| DRw10 \| HLA-DR1B \| HLA-DRB \| SS1	major histocompatibility complex, class II, DR beta 1	6p21.3
3125	HLA-DRB3	DRB1 \| DRw10 \| HLA-DR1B \| HLA-DR3B \| HLA-DRB \| SS1	major histocompatibility complex, class II, DR beta 3	6p21.3
3127	HLA-DRB5	HLA-DRB	major histocompatibility complex, class II, DR beta 5	6p21.3
7124	TNF	DIF \| TNF-alpha \| TNFA \| TNFSF2 \| TNLG1F	tumor necrosis factor	6p21.3
1432	MAPK14	CSBP \| CSBP1 \| CSBP2 \| CSPB1 \| EXIP \| Mxi2 \| PRKM14 \| PRKM15 \| RK \| SAPK2A \| p38 \| p38ALPHA	mitogen-activated protein kinase 14	6p21.3-p21.2
6885	MAP3K7	MEKK7 \| TAK1 \| TGF1a	mitogen-activated protein kinase kinase kinase 7	6q15
653361	NCF1	NCF1A \| NOXO2 \| SH3PXD1A \| p47phox	neutrophil cytosolic factor 1	7q11.23
3717	JAK2	JTK10 \| THCYT3	Janus kinase 2	9p24
7099	TLR4	ARMD10 \| CD284 \| TLR-4 \| TOLL	toll like receptor 4	9q33.1
2002	ELK1	-	ELK1, ETS transcription factor	Xp11.2
3654	IRAK1	IRAK \| pelle	interleukin 1 receptor associated kinase 1	Xq28